Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?

December 12, 2020
By United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
Series: ACIP meeting COVID-19 Vaccines

English

Details Related Documents You May Also Like

Details:

Corporate Authors:

United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA)
Description:

COVID-04-VOTE-508.pdf
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Pandemics Vaccination Viral Vaccines
Series:

ACIP meeting COVID-19 Vaccines
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine ; ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine

ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine ; ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine Less -
Genre:

Conference Publications
Volume:

2000211
Issue:

020104
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:b0c18e137e8af8d3a38439f03fb167bbaaa90edcf998ba0a5434b4351c41e7a6
Download URL:

https://stacks.cdc.gov/view/cdc/105437/cdc_105437_DS1.pdf
File Type:

[PDF-287.45 KB]